These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8498822)

  • 1. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
    Vermersch P; Delacourte A; Javoy-Agid F; Hauw JJ; Agid Y
    Ann Neurol; 1993 May; 33(5):445-50. PubMed ID: 8498822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases].
    Vermersch P; Bordet R; Ledoze F; Ruchoux MM; Chapon F; Thomas P; Destée A; Lechevallier B; Delacourte A
    C R Acad Sci III; 1995 Apr; 318(4):439-45. PubMed ID: 7648357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease.
    Mastaglia FL; Johnsen RD; Byrnes ML; Kakulas BA
    Mov Disord; 2003 Jan; 18(1):81-6. PubMed ID: 12518303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
    Xuereb JH; Tomlinson BE; Irving D; Perry RH; Blessed G; Perry EK
    Adv Neurol; 1990; 53():35-40. PubMed ID: 2173374
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyloid beta-peptide and the dementia of Parkinson's disease.
    Jendroska K; Lees AJ; Poewe W; Daniel SE
    Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation].
    Ebmeier KP; Besson JA; Cherryman G; Smith F
    Z Gerontol; 1988; 21(3):142-5. PubMed ID: 3407284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.
    Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
    Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter atrophy in early versus late dementia in Parkinson's disease.
    Beyer MK; Aarsland D
    Parkinsonism Relat Disord; 2008 Dec; 14(8):620-5. PubMed ID: 18394949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological differences between demented and nondemented patients with Parkinson's disease.
    Goodin DS; Aminoff MJ
    Ann Neurol; 1987 Jan; 21(1):90-4. PubMed ID: 3827218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of Lewy bodies in a consecutive autopsy series.
    Lindboe CF; Hansen HB
    Clin Neuropathol; 1998; 17(4):204-9. PubMed ID: 9707335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Argyrophilic grain disease (AgD), a frequent and largely underestimated cause of dementia in old patients].
    Probst A; Tolnay M
    Rev Neurol (Paris); 2002 Feb; 158(2):155-65. PubMed ID: 11965171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of the cortical lesions of the Parkinsonian-dementia (PD) complex of Guam.
    Tan NT; Kakulas BA; Masters CL; Chen KM; Gibbs CJ; Gajdusek DC
    Clin Exp Neurol; 1981; 17():227-34. PubMed ID: 6286187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
    Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
    Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A
    Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A; Boom A; Leroy K; Brion JP
    FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is "subcortical dementia" a recognizable clinical entity?
    Mayeux R; Stern Y; Rosen J; Benson F
    Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.